HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Immunotherapy, triplet regimens drive ‘unprecedented’ progress in myeloma
-
- The end(point) game in indolent lymphoma: After years-long search, data suggest genuine progress John Sweetenham, MD, FRCP, FACP
- FDA grants fast track status to OMS721 for atypical hemolytic uremic syndrome
- FDA grants orphan drug designation to dactinomycin formulation for Ewing's sarcoma
- FDA grants orphan drug designation to DPX-Survivac for ovarian cancer
- FDA grants orphan drug designation to melphalan for cholangiocarcinoma
- FDA grants orphan drug designation to veltuzumab for ITP
- FDA grants priority review of Tafinlar/Mekinist for adults with BRAF V600 mutation-positive melanoma
- ASCO issues recommendations for the inclusion of older adults in clinical trials
-
- Clinical, genetic factors associated with race influence warfarin dosage
- Comorbidities may have greater OS impact in CML than the malignancy
- Dabrafenib plus trametinib improves health-related quality of life in metastatic melanoma
- Dense breasts alone may not justify additional screening for breast cancer
- Extended anticoagulation beneficial after pulmonary embolism
- Family history of breast cancer not prognostic for recurrence
- Gene-expression classifier improves detection of lung cancer with bronchoscopy
- Nivolumab monotherapy demonstrates efficacy in previously treated NSCLC
-
- NRAS mutations improve response to immunotherapies in advanced melanoma
- Oncologists criticize high drug costs, propose cost-cutting measures
- Prognostic significance of OPSCC tumor stage has increased over time
- Prostate cancer diagnosis rates significantly decrease following USPSTF guideline revision
- Study: No benefit from anticoagulant use in Behçet’s disease
- TAS-102 significantly improves OS in refractory colorectal cancer
- Treatment type, location influence survival outcomes for oral cavity cancer
- Wells DVT score for inpatients inadequate to alter management approach
-
- Younger age predicts worse survival from low-grade serous carcinoma of ovary, peritoneum
- GW Cancer Center selects inaugural director
- MD Anderson names new vice provost
- Vanderbilt appoints director of pediatric stem cell transplant program
- Breast-feeding for 6 months or more reduces risk for childhood leukemia
- Delaying cord clamping improves neurodevelopment at 4 years